Comment on: Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza

Míreanna Comhchosúla

• Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection
  le: Malakhov, Michael P., et al.
  Foilsithe: (2006)
• DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: an in vitro pharmacodynamic analysis
  le: Triana-Baltzer, Gallen B., et al.
  Foilsithe: (2010)
• Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181
  le: Triana-Baltzer, Gallen B., et al.
  Foilsithe: (2011)
• Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein.
  le: Gallen B Triana-Baltzer, et al.
  Foilsithe: (2009-11-01)
• Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein
  le: Triana-Baltzer, Gallen B., et al.
  Foilsithe: (2009)